Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lang, Todd M."'
Autor:
Lang, Todd M.
Ex-post intraday market-risk extrema are compared with ex-ante standard RiskMetrics parametric Value-at-Risk (VaR) limits for three foreign currency futures markets (British Pound, Japanese Yen, Swiss Frank) to determine whether forecasted volatility
Externí odkaz:
http://hdl.handle.net/10919/36361
http://scholar.lib.vt.edu/theses/available/etd-12212000-222116/
http://scholar.lib.vt.edu/theses/available/etd-12212000-222116/
Autor:
Sussex, Roland1 sussex@uq.edu.au
Publikováno v:
Higher Education (00181560). Jan2008, Vol. 55 Issue 1, p121-137. 17p. 1 Chart.
Autor:
Christopher H. Lieu, Jeremy Shulman, Julie E. Lang, Todd M. Pitts, Stacey M. Bagby, Alexis D. Leal, Wells A. Messersmith, S. Lindsey Davis, Natalie M. Navarro, Jessica Barkow, Angela Minic, Sarah J. Hartman, Kimberly R. Jordan, Betelehem W. Yacob
Publikováno v:
Cancer Research. 80:6647-6647
Immunotherapies that target immune regulatory checkpoints such as CTLA-4 and PD-1 are widely used among many cancer types and have shown positive results in CRC with high microsatellite instability. However, in microsatellite stable (MSS) CRC there i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3545dad5bcbe61948e1e495edff35b05
https://doi.org/10.1158/1538-7445.am2020-6647
https://doi.org/10.1158/1538-7445.am2020-6647
Autor:
Anna Capasso, Todd M. Pitts, Stacey M. Bagby, Julie Lang, Roberta Pelanda, Kimberly R. Jordan, Scott Kopetz, Sarah Lindsey Davis, S. Gail Eckhardt, Wells A. Messersmith, Christopher H. Lieu
Publikováno v:
Molecular Cancer Therapeutics. 17:A012-A012
Introduction: Recent data have demonstrated that patients with MSI-H metastatic CRC are more likely to respond to a PD-1 inhibitor as a single agent compared to patients with MSS CRC. Effective immunotherapy approaches for MSS CRC remain a critical u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4e789ac57821742ba903cc5d67aedab
https://doi.org/10.1158/1535-7163.targ-17-a012
https://doi.org/10.1158/1535-7163.targ-17-a012
Autor:
Roberta Pelanda, Scott Kopetz, Christopher H. Lieu, Gail Eckhardt, Jill E. Slansky, Sarah Lindsey Davis, Stacey M. Bagby, Anna Capasso, John J. Tentler, Todd M. Pitts, Julie E. Lang, Paul Francoeur
Publikováno v:
Cancer Research. 77:1662-1662
Introduction: Agents that reverse T cell inhibitory signals have reinvigorated the strategy of cancer immunotherapy and are leading to robust clinical responses. In colorectal cancer (CRC), objective responses to single-agent therapy with anti-PD-1/P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13571125456cdbb8dcc78f91286162e8
https://doi.org/10.1158/1538-7445.am2017-1662
https://doi.org/10.1158/1538-7445.am2017-1662
Autor:
Stacey M. Bagby, S. Gail Eckhardt, Jill E. Slansky, S. Lindsey Davis, Roberta Pelanda, Christopher H. Lieu, John J. Tentler, Anna Capasso, Aik Choon Tan, Todd M. Pitts, Julie E. Lang
Publikováno v:
Clinical Cancer Research. 22:PR03-PR03
Introduction: Inhibiting the activity of the epidermal growth factor receptor (EGFR) with monoclonal antibodies has been utilized as a therapeutic strategy for patients with metastatic colorectal cancer (CRC), leading to improved clinical results alo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3c3492cc48c2a955185f67a2ea167bf
https://doi.org/10.1158/1557-3265.pdx16-pr03
https://doi.org/10.1158/1557-3265.pdx16-pr03